Symbole | YTM % | Volume | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
---|---|---|---|---|---|---|---|---|---|
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,45% | 15 K | 86,00% | 5,25% | 2043-08-15 | 4,064 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
BMY.GCBristol-Myers Squibb Company 6.875% 01-AUG-2097 | 6,02% | 30 K | 119,38% | 6,88% | 2097-08-01 | 62,417 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 5,94% | 40 K | 87,86% | 5,00% | 2045-08-15 | 15,709 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5,92% | 290 K | 97,64% | 5,70% | 2040-10-15 | 2,299 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 5,89% | 100 K | 78,85% | 4,35% | 2047-11-15 | 13,567 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
US110122EC8BRIST.MYERS 23/63 | 5,80% | 0 | 111,03% | 6,40% | 2063-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 5,67% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,204 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
US110122EL8BRIST.MYERS 24/64 | 5,63% | 0 | 100,39% | 5,65% | 2064-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122EB0BRIST.MYERS 23/53 | 5,63% | 0 | 109,98% | 6,25% | 2053-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5007349Bristol-Myers Squibb Company 5.25% 15-AUG-2043 | 5,56% | 12,921 M | 96,23% | 5,25% | 2043-08-15 | 218,373 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122EK0BRIST.MYERS 24/54 | 5,52% | 0 | 100,42% | 5,55% | 2054-02-22 | 2,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5007348Bristol-Myers Squibb Company 5.7% 15-OCT-2040 | 5,43% | 10 K | 102,97% | 5,70% | 2040-10-15 | 151,011 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122EJ3BRIST.MYERS 24/44 | 5,41% | 0 | 101,13% | 5,50% | 2044-02-22 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5009250Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 5,39% | 360 K | 87,94% | 4,55% | 2048-02-20 | 1,235 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 5,39% | 50 K | 90,21% | 4,63% | 2044-05-15 | 3,691 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
BMY5009251Bristol-Myers Squibb Company 4.35% 15-NOV-2047 | 5,39% | 175 K | 85,26% | 4,35% | 2047-11-15 | 1,236 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BRMGBRISTOL-MYERS 13/44 | 5,39% | 0 | 88,74% | 4,50% | 2044-03-01 | 341,52 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5009252Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 5,35% | 70 K | 95,28% | 5,00% | 2045-08-15 | 741,723 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5009254Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 5,35% | 1,478 M | 83,48% | 4,25% | 2049-10-26 | 3,749 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5009253Bristol-Myers Squibb Company 4.625% 15-MAY-2044 | 5,35% | 532 K | 90,74% | 4,63% | 2044-05-15 | 744,719 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY.GNBristol-Myers Squibb Company 6.125% 01-MAY-2038 | 5,30% | 360 K | 108,19% | 6,13% | 2038-05-01 | 219,255 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5754772Bristol-Myers Squibb Company FRN 20-FEB-2026 | 5,30% | 105 K | 100,35% | 5,58% | 2026-02-20 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122DW5BRIST.MYERS 22/52 | 5,28% | 0 | 74,92% | 3,70% | 2052-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122DX3BRIST.MYERS 22/62 | 5,27% | 0 | 74,12% | 3,90% | 2062-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122DV7BRIST.MYERS 22/42 | 5,27% | 0 | 79,50% | 3,55% | 2042-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY3883364Bristol-Myers Squibb Company 3.25% 01-AUG-2042 | 5,25% | 168 K | 75,76% | 3,25% | 2042-08-01 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122DR6BRIST.MYERS 20/40 | 5,22% | 0 | 67,56% | 2,35% | 2040-11-13 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5007343Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 5,21% | 1,666 M | 88,49% | 4,13% | 2039-06-15 | 1,996 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122AP3BRISTOL-MYERS 2036 | 5,21% | 0 | 106,13% | 5,88% | 2036-11-15 | 279,22 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122DS4BRIST.MYERS 20/50 | 5,12% | 0 | 59,89% | 2,55% | 2050-11-13 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122DZ8BRIST.MYERS 23/33 | 5,01% | 0 | 106,57% | 5,90% | 2033-11-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122EH7BRIST.MYERS 24/34 | 4,99% | 0 | 101,58% | 5,20% | 2034-02-22 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122DY1BRIST.MYERS 23/31 | 4,87% | 0 | 104,78% | 5,75% | 2031-02-01 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122DU9BRIST.MYERS 22/32 | 4,86% | 0 | 88,05% | 2,95% | 2032-03-15 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122EG9BRIST.MYERS 24/31 | 4,82% | 0 | 101,55% | 5,10% | 2031-02-22 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4,68% | 52 K | 97,60% | 3,90% | 2028-02-20 | 43,838 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
BRMJBRISTOL-MYERS 17/27 | 4,64% | 0 | 96,95% | 3,25% | 2027-02-27 | 512,277 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122EF1BRIST.MYERS 24/29 | 4,62% | 0 | 101,08% | 4,90% | 2029-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5077468Bristol-Myers Squibb Company 1.45% 13-NOV-2030 | 4,59% | 546 K | 83,37% | 1,45% | 2030-11-13 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122ED6BRIST.MYERS 24/26 | 4,55% | 0 | 100,50% | 4,95% | 2026-02-20 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5007342Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | 4,55% | 942 K | 95,10% | 3,40% | 2029-07-26 | 2,373 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 4,54% | 50 K | 96,91% | 3,45% | 2027-11-15 | 16,548 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
US110122EE4BRIST.MYERS 24/27 | 4,52% | 0 | 100,82% | 4,90% | 2027-02-22 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
US110122DP0BRIST.MYERS 20/27 | 4,52% | 0 | 90,40% | 1,13% | 2027-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5007347Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | 4,47% | 416 K | 98,26% | 3,90% | 2028-02-20 | 1,45 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5077466Bristol-Myers Squibb Company 0.75% 13-NOV-2025 | 4,39% | 4,886 M | 96,37% | 0,75% | 2025-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5007346Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | 4,32% | 100 K | 97,53% | 3,45% | 2027-11-15 | 517,675 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5007345Bristol-Myers Squibb Company 3.875% 15-AUG-2025 | 4,31% | 334 K | 99,57% | 3,88% | 2025-08-15 | 228,734 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY5007341Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 4,31% | 5,756 M | 98,28% | 3,20% | 2026-06-15 | 1,744 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY.GBBristol-Myers Squibb Company 6.8% 15-NOV-2026 | 4,25% | 163 K | 104,96% | 6,80% | 2026-11-15 | 255,948 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. |
XS122674851BRISTOL-MYERS 15/35 | 3,30% | 0 | 86,10% | 1,75% | 2035-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. |
BMY4831828Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 2,64% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY4933148Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 2,47% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY4931963Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 2,47% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY4831826Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 2,31% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BRMHBRISTOL-MYERS 15/25 | 1,96% | 0 | 99,05% | 1,00% | 2025-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. |
BMY4831822Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 0,55% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,953 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY4831824Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | −0,12% | 0 | 116,69% | 3,40% | 2029-07-26 | 26,556 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY4945645Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | −1,11% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |
BMY4926518Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | −1,33% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |